Corium Announces Appointment of Eric H. Bjerkholt to Board of Directors
April 01, 2015 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., April 1, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports First Quarter Fiscal 2015 Financial Results
February 10, 2015 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 10, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Report First Quarter Fiscal 2015 Financial Results on Tuesday, February 10, 2015
February 03, 2015 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI) today announced that it will report financial results for the First Quarter Fiscal 2015 on Tuesday,...
Corium to Present at the 2015 Leerink Global Healthcare Conference
January 30, 2015 13:55 ET
|
Corium International, Inc.
MENLO PARK, Calif., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Announces Appointment of Ivan Gergel, M.D. to Board of Directors
December 08, 2014 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., Dec. 8, 2014 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Announces Closing of Expanded Term Loan Facility With CRG
December 04, 2014 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., Dec. 4, 2014 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports Fiscal Year-End 2014 Financial Results and Recent Corporate Developments
November 17, 2014 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., Nov. 17, 2014 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Report Fiscal Year-end 2014 Financial Results on Monday, November 17, 2014
November 11, 2014 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., Nov. 11, 2014 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI) today announced that it will report financial results for the fiscal year ended September 30, 2014 on...
Corium Announces Appointment of Paul Goddard, Ph.D. to Board of Directors
September 17, 2014 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports Third Fiscal Quarter 2014 Financial Results
August 12, 2014 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...